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Editorial on the Research Topic
Multimodal Tracking of Functional Data in Parkinson’s Disease and Related Disorders–Speech
and Language Neuromotor and Cognitive Assessment
Parkinson’s Disease (PD) and related disorders are a growing concern worldwide due to their
chronic nature, with enormous implications for national health systems. Indicatively, there were
∼2.5 million People diagnosed with PD (PwP) in 1990, and 6.1 million PwP in 2016 (GBD 2016
Parkinson’s Disease Collaborators, 2018), with prevalence and incidence rates expected to rise
further as the population grows older. Patients with these chronic disorders require treatment,
continual palliative attention, rehabilitation, and caregiving. An ad-hoc functional monitoring
allowing for a detailed data collection, dedicated to attempt a representation of the symptoms
in patients’ everyday life, is needed to provide actionable insights into symptom trajectories and
disease progression. Notably, wearable sensors have been used so far in PD, detecting tremor and
gait abnormalities for example. Functional Monitoring can be performed via Multimodal Tracking
using Machine Learning Methods. Multimodal Tracking relies on the use of simple non-invasive
methods applied to patients who are home-bound (thus enabling e.g., de-centralized clinical
trials) or are being treated in care associations. Tracking aims to collect data at different levels,
capitalizing on the diverse toolkit of sensors that is available and becoming increasingly affordable.
Machine Learning Methods process large amounts of implicitly related correlates from axial motor
symptoms, as limb movement, for instance in handwriting with speech-related symptoms affecting
respiration, phonation, articulation, and fluency. Different digital endpoints have been proposed
in the last years to monitor PD and related disorders’ patients. There has been an increased
focus on speech signal analysis, handwriting evaluation, gait, and body movement assessment, and
object handling, as well as cognitive testing. Multimodal Tracking related to Language and Speech
evaluation may, for example, refer to a combination of Surface Face and Limb Electromyography
(sFLEMG), Electroencephalography from speech-production related brain areas (EEG), 3D Face
and Limb Accelerometry (3DFLAcc), Facial Image Recognition and Monitoring (FIRM), Speech
Recordings (SR), Electropalatography (EPG), amongst others.
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The purpose of the Research Topic was to present a detailed
view of the current state of the art and provide a forum to
highlight current attempts of research work in this field, focusing
on speech production, language processing, writing and motor
abilities, that are notably and evidently affected in the progression
of the disorders, in particular PD.
Among the received submissions, 4 were ultimately accepted
for publication in this special issue. We summarize in brief the
contributions of those papers below, and encourage interested
readers to study the corresponding papers for further in-
depth information.
Chen et al. tackled the challenging problem where some PwP
may freeze during walking, known as Freezing of Gait (FoG).
They reported findings on 53 early- to mid-stage PD, where
participants were requested to perform six tasks of walking
adaptability following a standardized assessment program (C-
Gait). They presented evidence that carefully observed gait
assessment though C-Gait could provide further additional
information compared to traditional PD walking tests and lead
to more personalized monitoring FoG insights.
Letanneux et al. focused on the Non-Motor Symptoms (NMS)
in PD, and specifically on a lexical decision task to assess whether
(1) the mental lexicon is impaired in PwP and (2) performance is
affected by bradykinesia. The reported on 34 PwP (almost equally
split between “on” and “off” medication) who did not have
dementia symptoms and 19 age matched controls, performing a
lexical decision task and a motor task. They found that motor
task performance was not affected in PwP compared to matched
controls, however unmedicated PwP where slower than controls
to react to stimuli.
Lopez-de-Ipina et al. reported on Essential Tremor (ET)
integrating handwriting and neuroimaging analysis. They
analyzed data from 19 people diagnosed with ET who underwent
MRI assessment and completed an automated Archimedes’ spiral
task (considered the “the gold standard” reference test for the
clinical diagnosis of ET). They demonstrated how the analysis
of fine motor skills, as measured by an automated Archimedes’
spiral task, is correlated with neuroimaging biomarkers for ET.
They conclude that their findings confirm the concordance of
findings between the clinical examination and neuroimaging
results, even in low amplitude tremors.
Hidalgo-De la Guía et al. conducted an exploratory study
to investigate whether the neuromotor deficits in children
with the Smith–Magenis Syndrome (SMS) adversely affect
phonation as compared to typically developing children
without neuromotor deficits. They compared the phonatory
performance of 12 children with SMS aged 5–12 years old
with an age- and gender-matched cohort of 12 children,
using established acoustic measures which characterized
sustained vowel /a/ phonations. They provided evidence
that the neuromotor deficits that characterize children with
SMS may adversely affect laryngeal biomechanics and thus
vocal quality.
CONCLUSION
The articles in this topic highlight both the complexity and
the diversity of approaches in monitoring and assessing
the pathophysiology of different chronic neurological
disorders and provide new insights into potential approaches
toward assessment and management. Although these four
studies report on a small number of participants and
findings would need to be validated to larger cohorts, we
believe they make some very useful contributions to the
research literature.
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